Although faecal microbiota transplantation (FMT) has a well-established role in the treatment
of recurrent Clostridioides difficile infection (CDI), its widespread dissemination is limited by …

Background Short-chain fatty acids (SCFAs) play important physiological roles in human
health. Adverse effects on health are known with a low or excessive concentration of SCFAs …

Background & Aims Fecal microbiota transplantation (FMT) is used commonly for treatment
of Clostridioides difficile infections (CDIs), although prospective safety data are limited and …

Fecal microbiota transplantation (FMT) has been used as a core therapy for treating
dysbiosis-related diseases by remodeling gut microbiota. The methodology and technology …

Clostridioides (formerly Clostridium) difficile is the most important infectious cause of
antibiotic-associated diarrhea worldwide and a leading cause of healthcare-associated …

The methods of fecal microbiota transplantation (FMT) and the related results vary a lot
among centers worldwide. Therefore, methodologic standardization can improve the clinical …

Clostridioides difficile is an anaerobic Gram-positive and spore-forming bacterium. The
majority of C. difficile strains produce two toxins, A and B, associated with the development …

Background Faecal microbiota transplantation is an emerging therapeutic option,
particularly for the treatment of recurrent Clostridioides difficile infection. Stool banks that …

The development of high-throughput omics technologies represents an unmissable
opportunity for evidence-based prevention of adverse effects on human health. However …

Extensive research has elucidated the influence of the gut microbiota on human health and
disease susceptibility and resistance. We review recent clinical and laboratory-based …